Treatment of postoperative nausea and vomiting
- 4 October 2003
- Vol. 327 (7418) , 762-763
- https://doi.org/10.1136/bmj.327.7418.762
Abstract
Footnotes Competing interests MT has been a consultant to Pfizer, UK; to Sintetica, Switzerland, a manufacturer of droperidol; and to Merck, US, manufacturer of aprepitant. He has been invited to an international consensus meeting on postoperative nausea and vomiting (sponsored by Aventis, US), has received fees from lectures from MSD Switzerland and Pfizer Norway, and is a recipient of a PROSPER grant from the Swiss National Science Foundation (No 3233–051939.97/2).This publication has 11 references indexed in Scilit:
- Consensus Guidelines for Managing Postoperative Nausea and VomitingAnesthesia & Analgesia, 2003
- Difference in Risk Factors for Postoperative Nausea and VomitingAnesthesiology, 2003
- Editorial IIBritish Journal of Anaesthesia, 2002
- Treatment of established postoperative nausea and vomiting: a quantitative systematic reviewBMC Anesthesiology, 2001
- How Much Are Patients Willing to Pay to Avoid Postoperative Nausea and Vomiting?Published by Wolters Kluwer Health ,2001
- A rational approach to the control of postoperative nausea and vomiting: evidence from systematic reviews. Part I. Efficacy and harm of antiemetic interventions, and methodological issuesActa Anaesthesiologica Scandinavica, 2001
- Substance P (Neurokinin-1) Antagonist Prevents Postoperative Vomiting after Abdominal Hysterectomy ProceduresAnesthesiology, 2000
- French Survey of Anesthesia in 1996Anesthesiology, 1999
- Impact of covert duplicate publication on meta-analysis: a case studyBMJ, 1997
- A postoperative analysis of the patient's view of anaesthesia in a Netherlands’ teaching hospitalAnaesthesia, 1990